|
|
|
Volumn 106, Issue 6 Suppl, 1999, Pages 17-23
|
|
Efficacy and tolerability of long-term venlafaxine XR therapy for GAD. Results of long-term, double-blind, placebo-controlled studies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
ADULT;
ANALYSIS OF VARIANCE;
ANXIETY DISORDER;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELAYED RELEASE FORMULATION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
FEMALE;
HOSPITALIZATION;
HUMAN;
LONGITUDINAL STUDY;
MALE;
PATIENT SATISFACTION;
PSYCHOLOGICAL RATING SCALE;
RANDOMIZED CONTROLLED TRIAL;
STATISTICS;
TREATMENT OUTCOME;
ADULT;
ANALYSIS OF VARIANCE;
ANTI-ANXIETY AGENTS;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANXIETY DISORDERS;
DELAYED-ACTION PREPARATIONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LONGITUDINAL STUDIES;
MALE;
PATIENT SATISFACTION;
PSYCHIATRIC STATUS RATING SCALES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 4243625717
PISSN: None
EISSN: 19419260
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
